Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 0.56 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.56 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.56 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.56 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CTSD | P07339 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24066703 | 1.00 | ABCB1 (0.56) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL24066725 | 0.94 | ABCB1 (0.55) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL25873517 | 0.94 | ABCB1 (0.55) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL14440139 | 0.94 | ABCB1 (0.62) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL24066659 | 0.94 | ABCB1 (0.62) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL14459537 | 0.90 | ABCB1 (0.59) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL16803020 | 0.89 | ABCB1 (0.67) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL13140395 | 0.89 | ABCB1 (0.67) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL8231341 | 0.89 | ABCB1 (0.67) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL691692 | 0.89 | ABCB1 (0.67) | ABCB1KCNE1KCNQ1KCNH2SCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212203-A1 | Antiviral Compounds | UNIVERSITY OF MASSACHUSETTS | 2023-07-06 | — | — | US | disclosed |
| US-20230212203-A1 | Antiviral Compounds | UNIVERSITY OF MASSACHUSETTS | 2023-07-06 | — | — | US | disclosed |
| US-11542288-B2 | Antiviral compounds | UNIVERSITY OF MASSACHUSETTS (US) | 2023-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542288-B2 | Antiviral compounds | ZC3HAV1, EIF2AK2, MAVS | ABCB1 411/4885KCNE1 4465/4885KCNQ1 4767/4885 |
| US-20230212203-A1 | Antiviral Compounds | ZC3HAV1, EIF2AK2, MAVS | ABCB1 411/4885KCNE1 4465/4885KCNQ1 4767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.